Relay Therapeutics: Funding, Investors & Team (Oct 2026)
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.
Relay Therapeutics has raised $575M across 2 funding rounds on record, the most recent an undisclosed round of $275M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Relay Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Relay Therapeutics Funding Rounds
Relay Therapeutics raised $300M in a Post-IPO Equity announced in Sep 2022.
3.7 years later, an undisclosed round of $275M was announced in May 2026.
Relay Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Relay Therapeutics Funding Compared to Other Biotechnology Startups
Relay Therapeutics' latest round of $275M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Relay Therapeutics in Biotechnology and Cambridge
Companies Similar to Relay Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Relay Therapeutics Funding FAQs
What does Relay Therapeutics do?
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.
How much funding has Relay Therapeutics raised?
Relay Therapeutics has raised $575M across 2 rounds on record. The most recent is an undisclosed round of $275M announced in May 2026.
When did Relay Therapeutics last raise funding?
Relay Therapeutics' most recent funding round on record is an undisclosed round of $275M, announced in May 2026.
Who is the CEO of Relay Therapeutics?
Sanjiv Patel is listed as CEO at Relay Therapeutics.
Where is Relay Therapeutics headquartered?
Relay Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Relay Therapeutics have?
Relay Therapeutics is in the 251-500 employee band.
How does Relay Therapeutics' funding compare to other Biotechnology startups?
Relay Therapeutics' latest round of $275M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Relay Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Relay Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.